MeSH term
Frequency | Condition_Probility | Humans | 269 | 0.0 |
Aged | 11 | 0.0 |
Time Factors | 15 | 0.0 |
Animals | 138 | 0.0 |
*Colorectal Neoplasms/diagnosis/metabolism/pathology/therapy | 2 | 3.0 |
3T3 Cells | 16 | 0.0 |
Cell Cycle/genetics | 10 | 6.0 |
*Cell Cycle Proteins | 162 | 13.0 |
Cell Differentiation/*physiology | 4 | 1.0 |
Cell Division/*physiology | 2 | 1.0 |
Cell Nucleus/genetics/metabolism | 2 | 5.0 |
Female | 39 | 0.0 |
Gene Expression Regulation/physiology | 6 | 2.0 |
Male | 35 | 0.0 |
Mice | 82 | 0.0 |
Mice, Knockout | 10 | 0.0 |
Promoter Regions (Genetics)/physiology | 4 | 2.0 |
Protein Binding/genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 189 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 130 | 0.0 |
Trans-Activation (Genetics)/genetics | 2 | 2.0 |
DNA/metabolism | 3 | 0.0 |
*DNA-Binding Proteins | 130 | 7.0 |
Genetic Vectors | 6 | 0.0 |
Transcription Factors/metabolism | 27 | 1.0 |
Apoptosis/genetics | 3 | 1.0 |
Cell Transformation, Neoplastic/*genetics | 4 | 2.0 |
DNA Damage | 3 | 0.0 |
Gamma Rays | 4 | 1.0 |
Genetic Vectors/genetics | 3 | 1.0 |
Mitosis | 3 | 0.0 |
p14ARF Protein/*metabolism | 2 | 11.0 |
Apoptosis | 17 | 0.0 |
Blotting, Western | 23 | 0.0 |
Cell Line | 71 | 0.0 |
Cyclins/*metabolism | 3 | 1.0 |
Enzyme Inhibitors/pharmacology | 7 | 0.0 |
Gene Expression Regulation | 27 | 0.0 |
Luciferases/metabolism | 8 | 1.0 |
*Nuclear Proteins | 10 | 0.0 |
Plasmids | 2 | 0.0 |
Promoter Regions (Genetics) | 45 | 1.0 |
Retinoblastoma Protein/physiology | 4 | 11.0 |
Signal Transduction | 11 | 0.0 |
Trans-Activation (Genetics)/*physiology | 6 | 5.0 |
Transcription Factors/genetics/*metabolism | 26 | 3.0 |
Transfection | 53 | 0.0 |
Base Sequence | 60 | 0.0 |
Binding Sites | 43 | 0.0 |
Cell Cycle Proteins/metabolism | 13 | 3.0 |
Chromatin/metabolism | 9 | 3.0 |
Enzyme Inhibitors | 3 | 3.0 |
Molecular Sequence Data | 57 | 0.0 |
*Promoter Regions (Genetics) | 15 | 0.0 |
Recombinant Fusion Proteins/metabolism | 12 | 0.0 |
Recombinant Proteins/metabolism | 6 | 0.0 |
Sequence Deletion | 5 | 0.0 |
Transcription Factor, Sp1/*metabolism | 5 | 1.0 |
Transcription Factors/*metabolism | 61 | 3.0 |
Transcription, Genetic | 30 | 0.0 |
Tumor Cells, Cultured | 61 | 0.0 |
Antineoplastic Agents/*pharmacology | 4 | 0.0 |
Breast Neoplasms/pathology | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 16 | 0.0 |
Hela Cells | 26 | 0.0 |
Histone Deacetylases/metabolism | 3 | 3.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 13 | 0.0 |
Adult | 8 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Apoptosis/*genetics | 6 | 2.0 |
Case-Control Studies | 2 | 0.0 |
Cyclin-Dependent Kinases/genetics | 3 | 5.0 |
DNA-Binding Proteins/genetics | 7 | 0.0 |
Middle Aged | 14 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
*Proto-Oncogene Proteins | 13 | 0.0 |
*Saccharomyces cerevisiae Proteins | 8 | 0.0 |
Transcription Factors/genetics | 6 | 0.0 |
Cell Cycle Proteins/*genetics/metabolism | 2 | 3.0 |
Cloning, Molecular | 14 | 0.0 |
DNA Primers | 14 | 0.0 |
Enzyme Activation | 7 | 0.0 |
Genes, Reporter | 16 | 0.0 |
Luciferases/genetics | 3 | 0.0 |
Restriction Mapping | 3 | 0.0 |
*Transcription, Genetic | 16 | 0.0 |
Fibroblasts/cytology/physiology | 4 | 5.0 |
Protein p53/*physiology | 3 | 2.0 |
Retinoblastoma Protein/*physiology | 2 | 6.0 |
Transcription Factors/*physiology | 11 | 2.0 |
DNA-Binding Proteins/*genetics | 6 | 0.0 |
Dimerization | 4 | 0.0 |
Exons | 3 | 0.0 |
Gene Deletion | 10 | 0.0 |
*Gene Expression Regulation, Neoplastic | 6 | 0.0 |
Models, Genetic | 12 | 0.0 |
Mutation | 23 | 0.0 |
Nuclear Proteins/*genetics | 5 | 0.0 |
Protein Binding | 44 | 0.0 |
Cells, Cultured | 38 | 0.0 |
Genes, myc | 5 | 1.0 |
Genes, p16 | 3 | 3.0 |
Genes, p53 | 3 | 0.0 |
Protein p16/metabolism | 4 | 7.0 |
Protein p53/metabolism | 14 | 2.0 |
Alzheimer Disease/*metabolism | 2 | 0.0 |
Cell Cycle | 18 | 1.0 |
Cell Cycle Proteins/genetics/*metabolism | 8 | 5.0 |
Immunohistochemistry | 12 | 0.0 |
Neurons/*metabolism | 2 | 0.0 |
Phosphorylation | 39 | 0.0 |
Retinoblastoma Protein/*metabolism | 24 | 12.0 |
Gene Expression Profiling | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 6 | 0.0 |
RNA, Messenger/analysis | 6 | 0.0 |
Reproducibility of Results | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 27 | 0.0 |
*Trans-Activation (Genetics) | 13 | 1.0 |
Adenoviridae/genetics | 8 | 1.0 |
Comparative Study | 20 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 12 | 1.0 |
Electrophoretic Mobility Shift Assay | 6 | 1.0 |
Gene Silencing | 2 | 0.0 |
*Proto-Oncogene Proteins c-bcl-2 | 3 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Repressor Proteins/genetics/*metabolism | 4 | 2.0 |
Response Elements | 4 | 1.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Cell Nucleus/metabolism | 16 | 0.0 |
Cytoplasm/metabolism | 5 | 0.0 |
Disease Models, Animal | 4 | 0.0 |
Macaca mulatta | 3 | 0.0 |
Retinoblastoma Protein/metabolism | 30 | 8.0 |
Species Specificity | 3 | 0.0 |
*Apoptosis | 13 | 0.0 |
Flow Cytometry | 11 | 0.0 |
*Gene Expression Regulation | 19 | 0.0 |
In Situ Nick-End Labeling | 4 | 0.0 |
Protein Structure, Tertiary | 14 | 0.0 |
Repressor Proteins/genetics/metabolism | 2 | 2.0 |
Substrate Specificity | 5 | 0.0 |
Transcription Factors/chemistry/genetics/*metabolism | 5 | 3.0 |
Transcription, Genetic/*genetics | 3 | 1.0 |
Two-Hybrid System Techniques | 5 | 0.0 |
Transcription Factor, Sp1/physiology | 2 | 5.0 |
English Abstract | 3 | 0.0 |
Gene Expression Regulation/genetics | 2 | 1.0 |
Promoter Regions (Genetics)/genetics | 9 | 0.0 |
Rats | 17 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Apoptosis/*physiology | 11 | 1.0 |
Mice, Transgenic | 15 | 0.0 |
Protein p53/*metabolism | 6 | 1.0 |
S Phase | 17 | 5.0 |
Cell Aging/*physiology | 5 | 9.0 |
Fibroblasts/cytology/metabolism | 2 | 1.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Mice, Inbred C57BL | 6 | 0.0 |
*Oncogenes | 3 | 0.0 |
Signal Transduction/physiology | 8 | 0.0 |
*Trans-Activators | 7 | 1.0 |
p14ARF Protein/metabolism | 2 | 12.0 |
Cell Division | 36 | 0.0 |
Endothelium, Vascular/cytology/*metabolism | 2 | 1.0 |
Gene Expression | 10 | 0.0 |
Precipitin Tests | 14 | 0.0 |
Alleles | 5 | 0.0 |
Cell Survival | 3 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
In Situ Hybridization | 5 | 0.0 |
Models, Biological | 12 | 0.0 |
Pregnancy | 5 | 0.0 |
RNA, Messenger/genetics/metabolism | 6 | 0.0 |
Retinoblastoma Protein/genetics/*metabolism | 6 | 13.0 |
Cell Division/drug effects | 9 | 0.0 |
Transcription Factors/*genetics | 16 | 0.0 |
Jurkat Cells | 7 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Repressor Proteins/genetics/*physiology | 3 | 8.0 |
S Phase/genetics | 4 | 19.0 |
Cell Division/physiology | 7 | 0.0 |
Cyclins/metabolism | 7 | 1.0 |
Enzyme Inhibitors/metabolism | 2 | 0.0 |
Epithelial Cells/metabolism/pathology | 2 | 4.0 |
Nuclear Proteins/metabolism | 8 | 0.0 |
Protein p53/genetics/*metabolism | 2 | 1.0 |
Signal Transduction/*physiology | 4 | 0.0 |
p14ARF Protein/genetics/*metabolism | 2 | 22.0 |
Cyclin A/*metabolism | 2 | 5.0 |
*DNA Damage | 7 | 1.0 |
DNA-Binding Proteins/genetics/metabolism | 6 | 1.0 |
Neoplasm Proteins/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 6 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
Hamsters | 6 | 0.0 |
Mammals | 3 | 0.0 |
Nuclear Proteins/*genetics/metabolism | 3 | 2.0 |
Sequence Homology, Amino Acid | 10 | 0.0 |
Dose-Response Relationship, Drug | 11 | 0.0 |
Glutathione Transferase/metabolism | 4 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Immunoblotting | 8 | 0.0 |
Microscopy, Fluorescence | 5 | 0.0 |
Plasmids/metabolism | 8 | 0.0 |
Amino Acid Sequence | 24 | 0.0 |
Binding Sites/genetics | 10 | 1.0 |
Blotting, Northern | 9 | 0.0 |
Cell Cycle Proteins/*genetics | 3 | 1.0 |
Promoter Regions (Genetics)/*genetics | 9 | 1.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Trans-Activation (Genetics) | 19 | 1.0 |
Brain/metabolism | 2 | 0.0 |
*CDC2-CDC28 Kinases | 9 | 1.0 |
Cell Cycle/physiology | 8 | 2.0 |
Cyclin E/genetics | 2 | 20.0 |
DNA | 5 | 0.0 |
Protein-Serine-Threonine Kinases/genetics | 2 | 1.0 |
Proto-Oncogene Proteins/*genetics | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 11 | 0.0 |
Genes, Tumor Suppressor | 5 | 0.0 |
Mice, Nude | 6 | 0.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
Cell Differentiation | 13 | 0.0 |
Chromatin/*metabolism | 2 | 1.0 |
*Cloning, Molecular | 2 | 0.0 |
Homeodomain Proteins/genetics | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Proteins/genetics | 2 | 0.0 |
U937 Cells | 3 | 0.0 |
Up-Regulation | 14 | 0.0 |
Cyclin-Dependent Kinases/antagonists & inhibitors/metabolism | 2 | 3.0 |
DNA/genetics/metabolism | 5 | 1.0 |
DNA Footprinting | 2 | 0.0 |
Deoxyribonuclease I/metabolism | 2 | 1.0 |
Plasminogen Activator Inhibitor 1/*genetics | 2 | 5.0 |
Retinoblastoma Protein/genetics/metabolism | 6 | 17.0 |
Treatment Outcome | 2 | 0.0 |
*Gene Expression Profiling | 3 | 0.0 |
Oligonucleotide Array Sequence Analysis/*methods | 4 | 3.0 |
Proto-Oncogene Proteins c-myc/*physiology | 3 | 7.0 |
Transcription Factors/biosynthesis/genetics | 2 | 2.0 |
Apoptosis/drug effects/*physiology | 2 | 0.0 |
Caspases/metabolism | 4 | 0.0 |
Cell Survival/drug effects | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 5 | 0.0 |
Transcription Factors/biosynthesis/*genetics | 3 | 2.0 |
*Carrier Proteins | 96 | 16.0 |
Culture Media, Serum-Free | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Introns/genetics | 2 | 0.0 |
Macromolecular Substances | 4 | 0.0 |
Mutation/genetics | 2 | 0.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Response Elements/*genetics | 2 | 3.0 |
Transcription, Genetic/genetics | 3 | 0.0 |
Acetyltransferases/*metabolism | 2 | 2.0 |
*DNA Repair | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 28 | 1.0 |
Nuclear Proteins/*metabolism | 11 | 1.0 |
Trans-Activators/*metabolism | 5 | 0.0 |
Cell Cycle Proteins/*analysis | 2 | 11.0 |
Cell Nucleus/chemistry | 2 | 1.0 |
DNA Mutational Analysis | 4 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Phenotype | 6 | 0.0 |
Retinoblastoma Protein/analysis/metabolism | 2 | 40.0 |
Transcription Factors/analysis | 2 | 2.0 |
Carrier Proteins/genetics/*metabolism | 4 | 0.0 |
Cell Line, Tumor | 20 | 0.0 |
Gene Expression Regulation, Neoplastic/genetics | 4 | 2.0 |
Animals, Newborn | 2 | 0.0 |
Cell Differentiation/*genetics | 3 | 3.0 |
DNA, Complementary/genetics | 4 | 0.0 |
Keratinocytes/metabolism | 2 | 1.0 |
Estradiol/*physiology | 2 | 13.0 |
Cell Division/genetics | 6 | 1.0 |
Mutagenesis/physiology | 2 | 2.0 |
Transcription, Genetic/*drug effects | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 4 | 0.0 |
Transcription Factors/genetics/metabolism | 6 | 1.0 |
Protein p53/analysis | 2 | 0.0 |
Retinoblastoma Protein/analysis | 2 | 5.0 |
Cell Nucleolus/metabolism | 2 | 5.0 |
Proteins/*metabolism | 3 | 0.0 |
p14ARF Protein | 3 | 3.0 |
COS Cells | 7 | 0.0 |
Receptor, erbB-3/*metabolism | 2 | 9.0 |
Cell Division/*drug effects | 4 | 1.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Transcription Factors/metabolism/*physiology | 3 | 3.0 |
Ubiquitins/*metabolism | 2 | 1.0 |
Gene Expression Regulation, Viral | 3 | 1.0 |
Cell Cycle/*drug effects | 2 | 1.0 |
RNA, Messenger/metabolism | 10 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Chromatography, Affinity | 4 | 0.0 |
Models, Molecular | 3 | 0.0 |
Protein Conformation | 3 | 0.0 |
Recombinant Proteins/chemistry/isolation & purification/metabolism | 2 | 2.0 |
Cattle | 3 | 0.0 |
Down-Regulation | 8 | 0.0 |
Transcription Factors/physiology | 3 | 1.0 |
Cell Cycle Proteins/*metabolism | 13 | 3.0 |
Phosphorylation/drug effects | 3 | 0.0 |
DNA Replication | 6 | 1.0 |
*Genes, Tumor Suppressor | 4 | 0.0 |
DNA Primers/genetics | 4 | 0.0 |
Gene Expression Regulation/drug effects | 4 | 0.0 |
Bromodeoxyuridine/metabolism | 2 | 2.0 |
Cell Cycle/*physiology | 12 | 4.0 |
DNA Primers/chemistry | 2 | 0.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Oncogenes | 2 | 0.0 |
Protein p16 | 4 | 2.0 |
Transcription Factors/antagonists & inhibitors | 2 | 18.0 |
Antineoplastic Agents/pharmacology | 5 | 0.0 |
Cell Cycle/drug effects | 8 | 1.0 |
Cyclins/*biosynthesis | 2 | 3.0 |
Flavonoids/pharmacology | 2 | 0.0 |
Neoplasm Transplantation | 2 | 0.0 |
Transcription Factors/*biosynthesis | 3 | 2.0 |
Transplantation, Heterologous | 2 | 0.0 |
Growth Inhibitors/*pharmacology | 2 | 1.0 |
Ligands | 2 | 0.0 |
*Proteins | 10 | 2.0 |
Transduction, Genetic | 2 | 0.0 |
Cytoplasm/chemistry | 2 | 1.0 |
*Gene Transfer Techniques | 2 | 0.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Carrier Proteins/*metabolism | 6 | 0.0 |
Cyclin E/metabolism | 5 | 4.0 |
Cyclin-Dependent Kinases/*metabolism | 3 | 1.0 |
Protein-Serine-Threonine Kinases/metabolism | 6 | 0.0 |
Protein p16/genetics | 2 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 6 | 0.0 |
CDC2-CDC28 Kinases/metabolism | 3 | 6.0 |
Cyclin D1/metabolism | 2 | 1.0 |
Cyclin-Dependent Kinases/metabolism | 9 | 2.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
NIH 3T3 Cells | 3 | 1.0 |
Proto-Oncogene Proteins c-myc/metabolism | 4 | 4.0 |
*S Phase | 2 | 3.0 |
Transcription, Genetic/*physiology | 3 | 1.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Tetrahydrofolate Dehydrogenase/genetics | 6 | 7.0 |
Gene Dosage | 2 | 0.0 |
G1 Phase | 11 | 3.0 |
Histone Deacetylases/*metabolism | 2 | 1.0 |
G1 Phase/*physiology | 2 | 4.0 |
Gene Expression Regulation/*physiology | 2 | 0.0 |
S Phase/*physiology | 2 | 4.0 |
Acetylation | 5 | 0.0 |
In Vitro | 6 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Cyclin D1/genetics | 2 | 3.0 |
Gene Expression Regulation, Neoplastic/*genetics | 2 | 1.0 |
Keratinocytes | 3 | 8.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Cell Division/*genetics | 2 | 3.0 |
Collagen/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Fibroblasts | 2 | 0.0 |
Cell Aging/*genetics | 3 | 10.0 |
Cell Cycle Proteins/genetics | 7 | 7.0 |
Osteosarcoma | 3 | 3.0 |
*Ultraviolet Rays | 2 | 0.0 |
S Phase/physiology | 5 | 6.0 |
*Tumor Suppressor Proteins | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
*Gene Expression | 3 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
DNA Fragmentation | 2 | 0.0 |
Fluorescent Antibody Technique | 5 | 0.0 |
Amino Acid Motifs | 3 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 4 | 0.0 |
Retinoblastoma Protein/chemistry/genetics/*metabolism | 2 | 50.0 |
Apoptosis/drug effects | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 4 | 0.0 |
G0 Phase | 2 | 2.0 |
Histones/metabolism | 2 | 0.0 |
Adenoviridae | 2 | 2.0 |
Phosphoproteins/metabolism | 4 | 0.0 |
Trans-Activators/genetics/*metabolism | 2 | 0.0 |
Genes, Reporter/genetics | 3 | 1.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 3 | 1.0 |
Trans-Activators/chemistry/genetics/*metabolism | 2 | 2.0 |
*Mutation | 2 | 0.0 |
DNA/biosynthesis | 4 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Cell Cycle Proteins/genetics/metabolism | 3 | 4.0 |
Retinoblastoma Protein/*genetics/metabolism | 2 | 28.0 |
Transcription Factors/*biosynthesis/*genetics | 4 | 12.0 |
Transcription Factor, Sp1/metabolism | 3 | 0.0 |
*Cell Cycle | 6 | 2.0 |
Gene Amplification | 4 | 0.0 |
Osteosarcoma/genetics/pathology | 2 | 33.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Receptors, Estrogen/metabolism | 2 | 0.0 |
Phosphoproteins/*metabolism | 5 | 1.0 |
Protein Binding/physiology | 2 | 0.0 |
Transfection/genetics | 2 | 1.0 |
Up-Regulation/physiology | 2 | 1.0 |
Cell Cycle/*radiation effects | 2 | 12.0 |
Transcription Factors/*biosynthesis/genetics | 2 | 2.0 |
Cell Division/drug effects/physiology | 2 | 0.0 |
Cyclins/biosynthesis/genetics | 2 | 4.0 |
Transcription Factors/biosynthesis | 2 | 2.0 |
Transforming Growth Factor beta/pharmacology | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Immediate-Early Proteins/*metabolism | 2 | 3.0 |
*Viral Proteins | 4 | 2.0 |
Transcription Factors/genetics/*physiology | 5 | 2.0 |
Oligodeoxyribonucleotides | 3 | 0.0 |
Protein p53/*genetics | 2 | 1.0 |
Down-Regulation/drug effects | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
Prognosis | 3 | 0.0 |
Mutagenesis | 3 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Cell Cycle Proteins/biosynthesis | 3 | 11.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 4 | 0.0 |
Antibiotics, Antineoplastic/*pharmacology | 2 | 1.0 |
HCT116 Cells | 2 | 8.0 |
S Phase/drug effects | 2 | 3.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 2 | 0.0 |
*Signal Transduction | 3 | 0.0 |
Cell Cycle/*genetics | 2 | 2.0 |
Cyclins/*genetics/metabolism | 3 | 6.0 |
Enzyme Inhibitors/*metabolism | 2 | 2.0 |
G1 Phase/genetics | 2 | 6.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
*Genes, ras | 3 | 1.0 |
DNA/*metabolism | 3 | 0.0 |
Histone Deacetylases/antagonists & inhibitors/*metabolism | 2 | 12.0 |
Homeostasis | 3 | 0.0 |
Cell Cycle Proteins/metabolism/*physiology | 2 | 13.0 |
Doxorubicin/pharmacology | 4 | 1.0 |
Histones/*metabolism | 3 | 2.0 |
Kinetics | 9 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
*Up-Regulation | 2 | 0.0 |
*Repressor Proteins | 5 | 0.0 |
*Transcription Factors | 3 | 0.0 |
Binding, Competitive | 2 | 0.0 |
*Drosophila Proteins | 3 | 0.0 |
DNA Probes | 2 | 0.0 |
Fungal Proteins/metabolism | 2 | 1.0 |
Cell Division/drug effects/genetics | 2 | 2.0 |
Protein Kinases/*metabolism | 3 | 0.0 |
Epithelial Cells | 4 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 5 | 0.0 |
RNA/metabolism | 2 | 0.0 |
Gene Transfer Techniques | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 9 | 2.0 |
Structure-Activity Relationship | 5 | 0.0 |
Apoptosis/physiology | 4 | 1.0 |
Transforming Growth Factor beta/*pharmacology | 2 | 0.0 |
Tetrahydrofolate Dehydrogenase/*genetics | 2 | 1.0 |
Transcription Factors/*genetics/*metabolism | 4 | 2.0 |
Adenocarcinoma/metabolism | 2 | 2.0 |
Protein p53/*biosynthesis | 2 | 1.0 |
Protein p53/biosynthesis | 2 | 1.0 |
G1 Phase/physiology | 2 | 2.0 |
Nuclear Proteins/*physiology | 3 | 2.0 |
Disease Progression | 2 | 0.0 |
Embryo | 3 | 0.0 |
Cyclin-Dependent Kinases/antagonists & inhibitors/*metabolism | 2 | 4.0 |
HT29 Cells | 2 | 1.0 |
Chromosome Mapping | 5 | 0.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis | 2 | 1.0 |
Cervix Neoplasms | 2 | 8.0 |
Genes, Retinoblastoma | 3 | 3.0 |
Skin/cytology | 2 | 1.0 |
Transcription Factors/*chemistry/*metabolism | 2 | 5.0 |
*Gene Expression Regulation, Viral | 2 | 0.0 |
Fetus | 2 | 0.0 |
Cell Transformation, Neoplastic | 3 | 0.0 |
Placenta/metabolism | 2 | 1.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
*Genes, p53 | 2 | 0.0 |
Chimeric Proteins | 2 | 2.0 |
Genes, Viral | 2 | 0.0 |
Molecular Weight | 2 | 0.0 |
Transforming Growth Factor beta/*metabolism | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Carcinoma, Squamous Cell/metabolism | 2 | 3.0 |
*Chromosomes, Human, Pair 20 | 2 | 1.0 |
Immunoprecipitation | 2 | 0.0 |
RNA Interference | 2 | 0.0 |
Proliferating Cell Nuclear Antigen/genetics | 2 | 6.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Histones/genetics | 2 | 9.0 |
5' Flanking Region | 2 | 3.0 |
Survival Rate | 2 | 0.0 |
Dyes/pharmacology | 2 | 2.0 |
Retroviridae/genetics | 2 | 0.0 |
Luciferases/genetics/metabolism | 2 | 0.0 |
Plasmids/genetics | 3 | 0.0 |
Protein p53/genetics/metabolism | 2 | 2.0 |
RNA, Messenger/drug effects/genetics/metabolism | 2 | 2.0 |
Nerve Tissue Proteins/*physiology | 2 | 3.0 |
Protein Transport | 2 | 0.0 |
G2 Phase | 2 | 1.0 |
Eukaryotic Cells/*metabolism | 2 | 4.0 |
Retinoblastoma Protein/genetics | 2 | 5.0 |
Active Transport, Cell Nucleus | 2 | 0.0 |
Mitochondria/metabolism | 2 | 0.0 |
Oligonucleotides, Antisense/chemistry | 2 | 8.0 |
Protein p53/biosynthesis/genetics | 2 | 4.0 |
Genes, Dominant | 2 | 0.0 |
Osteoblasts/metabolism | 2 | 3.0 |
Methylation | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 2 | 0.0 |
Glutathione Transferase/genetics/metabolism | 3 | 2.0 |
NF-kappa B/*metabolism | 2 | 0.0 |
Genes, p53/*physiology | 2 | 4.0 |
Cell Cycle/genetics/*physiology | 2 | 10.0 |
Cell Cycle Proteins/*physiology | 2 | 3.0 |
